TNF and COVID-19: 46% confirmed cases were hospitalized; 9% died. The use of non-steroidal anti-inflammatory drugs, antimalarials, conventional DMARD alone, or in combination with biologics/JAK inhibitors was not associated with hospitalization due to COVID-19. Glucocorticoid exposure of ≥10 mg/day was associated with a higher odds of hospitalization and anti-TNF with a decreased odds of hospitalization in pts. with rheumatic disease.